NeueHealth Inc expected to post a loss of $3.99 a share - Earnings Preview

Neuehealth

18/03/2025 12:48

NeueHealth Inc NEUE.N, NEUE.K is expected to show a fall in quarterly revenue when it reports  results on March 20 for the period ending December 31 2024

The Doral Florida-based  company is expected to report a 14.0% decrease in revenue to $251.93 million from $292.87 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

‚ÄãLSEG's mean analyst estimate for NeueHealth Inc is for a loss of $3.99 per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äã

Wall Street's median 12-month price target for NeueHealth Inc is $7.00‚Äã, above‚Äã its last closing price of $4.66. ‚Äã‚Äã‚Äã

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äã

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-2.73
-3.10
-3.92
Missed
-26.5
Jun. 30 2024
-3.26
-3.26
-7.27
Missed
-123
Mar. 31 2024
-5.30
-5.30
-7.54
Missed
-42.3‚Äã
Dec. 31 2023
-4.16
-4.16
20.05
Beat
582
‚Äã‚ÄãSep. 30 2023
-4.52
-4.36
-8.53
Missed
-95.6
Jun. 30 2023
-5.34
-5.45
-3.98
Beat
26.9‚Äã
Mar. 31 2023
-7.47
-7.60
-14.40
Missed
-89.5
Dec. 31 2022
-41.72
-40.80
-27.20
Beat
33.3

This summary was machine generated March 18 at 12:48 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)